|Articles|December 13, 2007
Trilostane: A new treatment option for dogs with hyperadrenocorticism (1:40)
Author(s)David S. Bruyette, DVM, DACVIM
"The advantage of trilostane seems to be a much higher safety profile than Lysodren with an equal efficacy rate."
Advertisement
Advertisement
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Advertisement
Related Content
Advertisement
